Cargando…

A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer

In this study a microRNA (miRNA) signature was identified in a gemcitabine resistant pancreatic ductal adenocarcinoma (PDAC) cell line model (BxPC3-GZR) and this signature was further examined in advanced PDAC tumor specimens from The Cancer Genome Atlas (TCGA) database. BxPC3-GZR showed a mesenchym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bera, Alakesh, VenkataSubbaRao, Kolaparthi, Manoharan, Muthu Saravanan, Hill, Ping, Freeman, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153643/ https://www.ncbi.nlm.nih.gov/pubmed/25184537 http://dx.doi.org/10.1371/journal.pone.0106343

Ejemplares similares

Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer
por: Venkatasubbarao, Kolaparthi, et al.
Publicado: (2013)

The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma
por: Ren, Le, et al.
Publicado: (2018)

Exosomal miRNA signatures of pancreatic lesions
por: Vicentini, Caterina, et al.
Publicado: (2020)

Identification of miRNAs contributing to neuroblastoma chemoresistance
por: Ayers, Duncan, et al.
Publicado: (2015)

Identification of chemoresistance-associated miRNAs in breast cancer
por: Lou, Weiyang, et al.
Publicado: (2018)

Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
por: Marengo, Barbara, et al.
Publicado: (2021)

MiRNA-mediated EMT and CSCs in cancer chemoresistance
por: Dong, Bing, et al.
Publicado: (2021)

Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021)

A Sequence-Dependent DNA Condensation Induced by Prion Protein
por: Bera, Alakesh, et al.
Publicado: (2018)

A quantitative characterization of interaction between prion protein with nucleic acids
por: Bera, Alakesh, et al.
Publicado: (2018)

MRI phenotypes in MS: Longitudinal changes and miRNA signatures
por: Hemond, Christopher C., et al.
Publicado: (2019)

miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer
por: Cai, Zhonglin, et al.
Publicado: (2019)

Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
por: Singh, Shivam, et al.
Publicado: (2023)

Identifying the miRNA Signature Association with Aging-Related Senescence in Glioblastoma
por: Gnanavel, Mutharasu, et al.
Publicado: (2021)

Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia
por: Vila-Navarro, Elena, et al.
Publicado: (2019)

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas
por: Barbano, Raffaela, et al.
Publicado: (2014)

Oncogenic K-Ras and Loss of Smad4 Mediate Invasion by Activating an EGFR/NF-κB Axis That Induces Expression of MMP9 and uPA in Human Pancreas Progenitor Cells
por: Bera, Alakesh, et al.
Publicado: (2013)

Chemoresistance in Pancreatic Cancer
por: Zeng, Siyuan, et al.
Publicado: (2019)

Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
por: Singh, Saurabh, et al.
Publicado: (2012)

An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance
por: Carta, Alessia, et al.
Publicado: (2014)

Chemoresistance, Cancer Stem Cells, and miRNA Influences: The Case for Neuroblastoma
por: Buhagiar, Alfred, et al.
Publicado: (2015)

Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review
por: Campos, America, et al.
Publicado: (2021)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
por: Palamaris, Kostas, et al.
Publicado: (2021)

Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis
por: Xie, Binbin, et al.
Publicado: (2018)

Desmoplasia and Chemoresistance in Pancreatic Cancer
por: Schober, Marvin, et al.
Publicado: (2014)

Pancreatic Cancer Chemoresistance to Gemcitabine
por: Amrutkar, Manoj, et al.
Publicado: (2017)

Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition
por: Qiu, Ling, et al.
Publicado: (2018)

Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
por: Rice, A J, et al.
Publicado: (2017)

Differential miRNA Expression: Signature for Glaucoma in Pseudoexfoliation
por: Rao, Aparna, et al.
Publicado: (2020)

The Role of Exosomes in Stemness and Neurodegenerative Diseases—Chemoresistant-Cancer Therapeutics and Phytochemicals
por: Beeraka, Narasimha M., et al.
Publicado: (2020)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance
por: Qin, Shuang, et al.
Publicado: (2023)

EVIDENCE FOR MESENCHYMAL-LIKE SUBPOPULATIONS WITHIN SQUAMOUS CELL CARCINOMAS POSSESSING CHEMORESISTANCE AND PHENOTYPIC PLASTICITY
por: Basu, Devraj, et al.
Publicado: (2010)

Role of pancreatic stellate cells in chemoresistance in pancreatic cancer
por: McCarroll, Joshua A., et al.
Publicado: (2014)

Exosomes and their roles in the chemoresistance of pancreatic cancer
por: Pan, Yubin, et al.
Publicado: (2022)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
por: Chen, Junliang, et al.
Publicado: (2023)

Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer
por: Chen, Shuoling, et al.
Publicado: (2021)

The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer
por: Kuwada, Kazuya, et al.
Publicado: (2018)

The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
por: Gulla, Aiste, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_df2fj6am9c9btmom0478feuk4b